title: Drugs in traffic: the road to approval.
mesh_terms: D000077713:17 alpha-Hydroxyprogesterone Caproate; D000069501:Abiraterone Acetate; D000225:Adenine / Q000031:analogs & derivatives / Q000494:pharmacology; D000730:Androstadienes / Q000494:pharmacology; D061067:Antibodies, Monoclonal, Humanized / Q000494:pharmacology; D016588:Anticarcinogenic Agents / Q000138:chemical synthesis; D001559:Benzhydryl Compounds; D000068258:Bevacizumab; D017277:Drug Approval; D004345:Drug Industry / Q000458:organization & administration*; D005960:Glucosides / Q000494:pharmacology; D006908:Hydroxyprogesterones / Q000494:pharmacology; D007189:Indans / Q000494:pharmacology; D009025:Morpholines / Q000494:pharmacology; D020097:Natriuretic Peptide, Brain / Q000494:pharmacology; D063065:Organophosphonates / Q000494:pharmacology; D011486:Protein C / Q000494:pharmacology; D011994:Recombinant Proteins / Q000494:pharmacology; D000069552:Rivaroxaban; D000068698:Tenofovir; D013876:Thiophenes / Q000494:pharmacology
chemical_list: D000730:Androstadienes; D061067:Antibodies, Monoclonal, Humanized; D016588:Anticarcinogenic Agents; D001559:Benzhydryl Compounds; D005960:Glucosides; D006908:Hydroxyprogesterones; D007189:Indans; D009025:Morpholines; D063065:Organophosphonates; D011486:Protein C; D011994:Recombinant Proteins; D013876:Thiophenes; C031967:rasagiline; D020097:Natriuretic Peptide, Brain; C529054:dapagliflozin; D000077713:17 alpha-Hydroxyprogesterone Caproate; D000068258:Bevacizumab; D000068698:Tenofovir; D000069552:Rivaroxaban; D000069501:Abiraterone Acetate; D000225:Adenine; C421124:drotrecogin alfa activated